Debiopharm, Yale University Extend Collaboration
News May 07, 2014
Debiopharm Group™ (Debiopharm) has announced that it has signed a new license and research agreement with Yale University (Yale), a premier university with a long tradition of basic and clinical biomedical research, regarding the discovery of MIF inhibitors for treatment of autoimmune and inflammatory diseases.
This joint effort will enable the discovery and development of potential oral first-in-class compounds that inhibit Macrophage Migration Inhibitory Factor (MIF), a key regulatory cytokine that has been linked genetically to the pathogenesis of several autoimmune and inflammatory diseases.
“We are very pleased to announce this new research collaboration with top-ranked Yale University. We are convinced that building a strong relationship with leading, medically-focused academic institutions is a productive way of creating drugs for tomorrow” said Thierry Mauvernay, Delegate of the Board, Debiopharm Group.
Yale researchers Richard Bucala, MD, PhD, Professor of Medicine, Epidemiology and Pathology, and William L. Jorgensen, PhD, Sterling Professor of Chemistry and Director of the Division of Physical Sciences and Engineering, are leading the Yale scientific team designing small molecule antagonists to block inflammation in patients.
“Debiopharm’s reputation for early stage drug development is well known, and this is an exciting new therapeutic approach that may ultimately allow us to tailor treatment to a patient’s immunogenetic profile,” said Bucala.
“The project is progressing well with great synergies between computer-aided molecular design, synthetic chemistry, crystallography and biology,” Jorgensen added. “We are delighted with Debiopharm's participation, which is essential for spearheading the preclinical and clinical efforts.”
"This is a great example of how scientists of academia and industry can put their efforts together to bring solutions to pressing medical needs in a more efficient manner" added Andrés McAllister, Chief Scientific Officer, Debiopharm International SA.
New Microscope Captures Detailed 3-D Movies of Cells Deep Within Living SystemsNews
Merging lattice light sheet microscopy with adaptive optics reveals the most detailed picture yet of subcellular dynamics in multicellular organisms.READ MORE
How Environmental Pollutants and Genetics Work Together in Rheumatoid ArthritisNews
It is well known that individuals with a particular version of human leukocyte antigen have an increased risk for rheumatoid arthritis, but there has been growing interest in the role of environmental pollutants. In a new mouse study, researchers probed the relationship between the two.READ MORE
Comments | 0 ADD COMMENT
International Conference on Analytical and Bio Analytical Techniques
Oct 31 - Nov 01, 2018
16th Annual Conference on Laboratory Medicine and Pathology
Sep 17 - Sep 18, 2018